Hitomi Ohkawa
-
- Scientific Computing and Data Management 2
-
- Biomedical Text Mining and Ontologies 2
- Gene expression and cancer classification 2
- Microbial Metabolic Engineering and Bioproduction 2
-
- Enzyme Structure and Function 1
-
- Genomics and Rare Diseases 1
-
- Computational Drug Discovery Methods 1
-
- Distributed and Parallel Computing Systems 1
- Co-authors
- Jonathan A. EpsteinGregory D. SchulerJonathan A. KansStephen H. BryantChristopher W.V. HogueJames OstellJuergen HammerJohn Shon
- Journals
- The FASEB Journal (1 paper)Trends in Biochemical Sciences (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Hitomi Ohkawa
6 papers receiving 389 citations
Peers
Comparison fields: 5 of 76
- Information Systems and Management 36
- Molecular Biology 340
- Artificial Intelligence 53
- Spectroscopy 24
- Materials Chemistry 62
Countries citing papers authored by Hitomi Ohkawa
This map shows the geographic impact of Hitomi Ohkawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Ohkawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Ohkawa more than expected).
Fields of papers citing papers by Hitomi Ohkawa
This network shows the impact of papers produced by Hitomi Ohkawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Ohkawa. The network helps show where Hitomi Ohkawa may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Hitomi Ohkawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Scientific workflows as productivity tools for drug discovery. | 2008 | 14 |
| 2 | 2003 | 30 | |
| 3 | 1996 | 295 | |
| 4 | 1996 | 48 | |
| 5 | MMDB: an ASN.1 specification for macromolecular structure. | 1995 | 20 |
| 6 | 1993 | 2 |
About Hitomi Ohkawa
Hitomi Ohkawa is a scholar working on Information Systems and Management, Computational Theory and Mathematics and Molecular Biology, having authored 6 papers that have together received 409 indexed citations. Recurring topics across this work include Biomedical Text Mining and Ontologies (2 papers), Gene expression and cancer classification (2 papers), Scientific Computing and Data Management (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers), Enzyme Structure and Function (1 paper), Genomics and Rare Diseases (1 paper), Computational Drug Discovery Methods (1 paper) and Distributed and Parallel Computing Systems (1 paper). The work is most often cited by research in Information Systems and Management (36 citations), Molecular Biology (340 citations) and Artificial Intelligence (53 citations). Hitomi Ohkawa has collaborated with scholars based in United States and Germany. Frequent co-authors include Jonathan A. Epstein, Gregory D. Schuler, Jonathan A. Kans, Stephen H. Bryant, Christopher W.V. Hogue, James Ostell, Juergen Hammer, John Shon, Gerhard Seitz and Holly Hilton. Their work appears in journals such as The FASEB Journal, Trends in Biochemical Sciences, Methods in enzymology on CD-ROM/Methods in enzymology, OHSU Digital Commons and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.